Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CLEC6A Stable Cell Line

    [CAT#: S01YF-1023-PY296]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Other Targets
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1
    Target Classification
    Other Targets Drug Discovery Assays and Products
    Target Research Area
    Infectious Research
    Related Diseases
    Cryptococcosis; Chromoblastomycosis
    Gene ID
    Human:93978
    UniProt ID
    Human:Q6EIG7

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The protein CLEC6A has been studied in various applications. In one study, it was found that CLEC6A, along with other biomarkers, was associated with cardiovascular disease in people with HIV. Another study showed that CLEC6A, along with other biomarkers, could be used to predict the severity of COVID-19. Additionally, CLEC6A was found to be involved in rumen development in calves and in reducing inflammation and oxidative stress in dairy cows. These findings suggest that CLEC6A has potential applications in understanding disease mechanisms and improving animal health.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human CLEC6A Stable Cell Line (S01YF-1023-PY296). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Peyton Garcia (Verified Customer)

    What is the role of CLEC6A in immune response? Nov 12 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    CLEC6A, also known as Dectin-2, plays a crucial role in immune response by activating macrophages and promoting the production of proinflammatory cytokines, which can be targeted for tumor immunotherapy. Nov 12 2020

    chat Jordan Miller (Verified Customer)

    How does CLEC6A expression affect diseases involving chronic inflammation? Jan 03 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Overexpression of CLEC6A is implicated in diseases with chronic inflammation, such as tumors, Crohn's disease, and psoriasis, indicating its potential as a therapeutic target. Jan 03 2023

    Published Data

    Fig.1 Reduction in HIV-EBOV GP infection, irrespective of the presence of MBL, was observed upon shRNA-mediated dectin-2 (CLEC6A) knockdown.

    Twenty-four candidate lectin, scavenger, and other putative receptors were targeted using pLKO.1 lentiviral vectors expressing 4 or 5 unique short hairpin RNA (shRNA) constructs per gene. HEK293F cells were transduced in quadruplicate with 4.6×10^8 viral particles (shRNA-expressing vectors or empty control vectors) and hexadimethrine bromide (6 µg/ml) at 37°C for 18 hours. Transduced cells were selected with 5 µg/ml puromycin over 48 hours. Subsequently, cells were infected in quadruplicate with HIV-EBOV GP virion-like particles (1000 pg p24/100 µl) in the presence or absence of rhMBL. After 48 hours, rates of single-round infection (luciferase assay) were measured, and the results were adjusted for cell viability. The percentage change in infection was normalized to the empty pLK0.1 control vector (CTRL).

    Ref: Brudner, Matthew, et al. "Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors." PloS one 8.4 (2013): e60838.

    Pubmed: 23573288

    DOI: 10.1371/journal.pone.0060838

    Research Highlights

    Wang, Jie. et al. "Integration of Non-Coding RNA and mRNA Profiles Reveals the Mechanisms of Rumen Development Induced by Different Types of Diet in Calves." Genes, 2023.
    In intensive dairy farming, selecting appropriate feed types and understanding gastrointestinal digestive mechanisms is crucial for the wellbeing and growth of calves. However, the impact of changing the molecular genetic basis and regulatory mechanism using different feed types on rumen development remains unclear. To address this, a study was conducted using nine Holstein bull calves, randomly allocated to three diet groups: GF (concentrate), GFF (alfalfa:oat grass = 3:2), and TMR (concentrate:alfalfa grass:oat grass:water = 0.30:0.12:0.08:0.50). After 80 days, rumen tissue and serum samples were collected for physiological and transcriptomic analysis. The results showed that the TMR group exhibited higher serum α-amylase and ceruloplasmin activity compared to the other groups. Furthermore, the TMR diet significantly enriched the pathways of rumen epithelial development and stimulated rumen cell growth, including the Hippo signaling pathway, Wnt signaling pathway, thyroid hormone signaling pathway, and absorption of protein and fat. The constructed circRNA/lncRNA-miRNA-mRNA networks, including novel_circ_0002471, novel_circ_0012104, TCONS_00946152, TCONS_00960915, bta-miR-11975, bta-miR-2890, PADI3, and CLEC6A, were found to participate in metabolic pathways related to lipid, immune system, oxidative stress, and muscle development. In summary, the TMR diet was found to improve rumen digestive enzyme activities, nutrient absorption, and the expression of differentially expressed genes associated with energy homeostasis and microenvironment balance. Therefore, it can be concluded that the TMR diet is more beneficial for promoting rumen growth and development compared to the GF and GFF diets.
    Wang, Jie. et al. "Integration of Non-Coding RNA and mRNA Profiles Reveals the Mechanisms of Rumen Development Induced by Different Types of Diet in Calves." Genes, 2023.
    Pubmed: 37239453   DOI: 10.3390/genes14051093

    S Reilly, Cavan. et al. "Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV." The Journal of infectious diseases, 2023.
    The association between individuals with HIV (PWH) and an increased risk for cardiovascular disease (CVD) is not fully understood. A study was conducted to determine if a set of biomarkers had a significant correlation with the occurrence of CVD among PWH. Through the use of Mendelian randomization (MR), potential causal associations were identified. The results of this research may lead to a better understanding of the relationship between HIV and CVD, ultimately aiding in the development of preventative and treatment strategies.
    S Reilly, Cavan. et al. "Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV." The Journal of infectious diseases, 2023.
    Pubmed: 36580481   DOI: 10.1093/infdis/jiac496

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare